Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details)

v3.22.2.2
Subsequent Events (Details) - $ / shares
1 Months Ended 12 Months Ended
Sep. 23, 2022
Jun. 30, 2021
Subsequent Events (Details) [Line Items]    
Common stock issued   164,653
Common stock, per share (in Dollars per share)   $ 213
Forecast [Member]    
Subsequent Events (Details) [Line Items]    
Subsequent events description On September 23, 2022, the Company entered into a Securities Purchase Agreement and issued and sold to an institutional investor, a Promissory Note in the principal sum of $700,000.00, which amount is the $644,000 actual amount of the purchase price plus an original issue discount in the amount of $56,000. In connection with the issuance of the note, the Company issued to the investor warrants to purchase 2,800,000 shares of common stock at an exercise price of $0.225, as well as returnable warrants to purchase 7,000,000 shares of common stock at an exercise price of $0.30, in each case subject to adjustment. As a result of the transaction, the Company’s existing lenders triggered their “most favored nation” clause which resulted in their existing notes receiving some of the same terms and conditions the Company granted to the new investor’s notes and warrants, including that the existing investors were issued returnable warrants to purchase an aggregate of 5,434,783 shares of common stock at an exercise price per share of $0.30 (subject to adjustment). As a result of the financing, the Company is required to pay cash fees to its bankers (including the Placement Agent), which amounts are being determined but will not be less than $$67,000, and to issue compensatory warrants to the Placement Agents to purchase 280,000 shares of common stock at an exercise price of $0.225, warrants to purchase 119,260 shares of common stock at an exercise price of $0.27, and returnable warrants to purchase 700,000 shares of common stock at an exercise price of $0.30, in each case subject to adjustment. This financing will cause an adjustment in the exercise price of the warrants associated with our Series B preferred stock, resulting in a new exercise price for those warrants of approximately $0.286 from their previous exercise price of $0.2919.  
Series B Preferred Stock [Member]    
Subsequent Events (Details) [Line Items]    
Converted shares   810
Common Class B [Member]    
Subsequent Events (Details) [Line Items]    
Common stock, per share (in Dollars per share)   $ 20
Converted shares   4,050,000